TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 8525691

Group type: EXPERIMENTAL
Intervention: Recombivax 10 micrograms
Number of subjects: 346

Group type: EXPERIMENTAL
Intervention: Recombivax 5 micrograms
Number of subjects: 346

Group type: EXPERIMENTAL
Intervention: Engerix 10 micrograms
Number of subjects: 346

Group type: EXPERIMENTAL
Intervention: Engerix 5 micrograms
Number of subjects: 346
Study: 2265160

Group type: EXPERIMENTAL
Intervention: 0.75% bupivacaine (8.25% dextrose)
Number of subjects: 22

Group type: COMPARATOR
Intervention: 1% tetracaine mixed with an equal volume of 10% procaine
Number of subjects: 22
Study: 455950

Group type: EXPERIMENTAL
Intervention: Pharmacotherapy
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Psychotherapy
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Nonscheduled therapy
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Combination of psychotherapy and pharmacotherapy
Number of subjects: 0
Study: 31832721

Group type: EXPERIMENTAL
Intervention: Ethanol (0.8 g/kg)
Number of subjects: 69

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 69
Study: 30840024

Group type: EXPERIMENTAL
Intervention: Higher baseline hsCRP levels
Number of subjects: 4257

Group type: EXPERIMENTAL
Intervention: Higher longitudinal hsCRP levels
Number of subjects: 4257
Study: 29044000

Group type: EXPERIMENTAL
Intervention: Shenqi Fuzheng Injection combined with Cefoxitin Sodium
Number of subjects: 126

Group type: COMPARATOR
Intervention: Cefoxitin Sodium
Number of subjects: 126
Study: 26512456

Group type: EXPERIMENTAL
Intervention: Free 25-hydroxyvitamin D (25[OH]D) levels measured directly by ELISA
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: Total serum 25(OH)D concentrations
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: Calculated serum free 25(OH)D levels
Number of subjects: 80

Group type: COMPARATOR
Intervention: Serum albumin and vitamin D binding protein (VDBP) levels
Number of subjects: 80
Study: 23798006

Group type: EXPERIMENTAL
Intervention: Androgen suppression therapy (AST) for 6 months
Number of subjects: 108

Group type: EXPERIMENTAL
Intervention: No/minimal comorbidity
Number of subjects: 108

Group type: EXPERIMENTAL
Intervention: Moderate/severe comorbidity
Number of subjects: 108

Group type: EXPERIMENTAL
Intervention: PSA velocity greater than the median
Number of subjects: 108

Group type: EXPERIMENTAL
Intervention: PSA velocity at or below the median
Number of subjects: 108
Study: 22772617

Group type: EXPERIMENTAL
Intervention: Nano-emulsion gel formulation of adapalene 0.1% and clindamycin 1%
Number of subjects: 209

Group type: COMPARATOR
Intervention: Conventional gel formulation of adapalene 0.1% and clindamycin 1%
Number of subjects: 209
Study: 19740402

Group type: COMPARATOR
Intervention: Positive control
Number of subjects: 74

Group type: EXPERIMENTAL
Intervention: BX471 at therapeutic doses
Number of subjects: 74

Group type: EXPERIMENTAL
Intervention: Regression-based QT correction methods
Number of subjects: 74
Study: 17289823

Group type: EXPERIMENTAL
Intervention: Attention and hypnosis
Number of subjects: 241

Group type: EXPERIMENTAL
Intervention: Hypnosis
Number of subjects: 241

Group type: COMPARATOR
Intervention: Standard care
Number of subjects: 241
Study: 15372178

Group type: EXPERIMENTAL
Intervention: Biken two-component (23.4 mg PT; 23.4 mg FHA) Pa vaccine (0.5 ml)
Number of subjects: 518
Study: 11386626

Group type: EXPERIMENTAL
Intervention: General public's QOL ratings after considering life domains
Number of subjects: 0

Group type: COMPARATOR
Intervention: General public's QOL ratings before considering life domains
Number of subjects: 0
Study: 9648703

Group type: EXPERIMENTAL
Intervention: 1 gm MSG
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: 5 gm MSG
Number of subjects: 12

Group type: COMPARATOR
Intervention: 5 gm lactose (placebo)
Number of subjects: 12
Study: 1561891

Group type: EXPERIMENTAL
Intervention: General neurotic syndrome
Number of subjects: 0
Study: 3986084

Group type: EXPERIMENTAL
Intervention: Amitriptyline hydrochloride (50 mg or 100 mg)
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Binodaline hydrochloride (50 mg or 100 mg)
Number of subjects: 12

Group type: COMPARATOR
Intervention: Lactose placebo
Number of subjects: 12
Study: 30803706

Group type: EXPERIMENTAL
Intervention: Spironolactone (maximum dose, 50mg/d) for 24 weeks
Number of subjects: 61

Group type: COMPARATOR
Intervention: Placebo for 24 weeks
Number of subjects: 61
Study: 29808469

Group type: EXPERIMENTAL
Intervention: MD1003 (300 mg/day)
Number of subjects: 93

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 93

Group type: EXPERIMENTAL
Intervention: MD1003
Number of subjects: 93
Study: 27895352

Group type: EXPERIMENTAL
Intervention: Low intra-abdominal pressure (10 mmHg)
Number of subjects: 160

Group type: COMPARATOR
Intervention: Standard intra-abdominal pressure (above 10 mmHg)
Number of subjects: 160
Study: 25140597

Group type: EXPERIMENTAL
Intervention: Supplement with ω6:ω3 ratio of 8:1 and arginine
Number of subjects: 26

Group type: EXPERIMENTAL
Intervention: Supplement with high ω9:ω6 ratio of 3.2:1 and low ω6:ω3 ratio of 1.4:1 and arginine
Number of subjects: 26

Group type: COMPARATOR
Intervention: Skim milk, 0% fat
Number of subjects: 26

Group type: EXPERIMENTAL
Intervention: All groups
Number of subjects: 26
Study: 23055131

Group type: EXPERIMENTAL
Intervention: Asian grocery store-based breast cancer education program
Number of subjects: 1540

Group type: COMPARATOR
Intervention: Prostate cancer program
Number of subjects: 1540
Study: 19306038

Group type: EXPERIMENTAL
Intervention: Citalopram (10 mg/day)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 20
Study: 17724802

Group type: COMPARATOR
Intervention: Omeprazole 20 mg/d
Number of subjects: 320

Group type: COMPARATOR
Intervention: Lansoprazole 30 mg/d
Number of subjects: 320

Group type: COMPARATOR
Intervention: Pantoprazole 40 mg/d
Number of subjects: 320

Group type: COMPARATOR
Intervention: Rabeprazole 20 mg/d
Number of subjects: 320
Study: 15241905

Group type: EXPERIMENTAL
Intervention: Essential oil mouthrinse (Listerine Antiseptic)
Number of subjects: 19

Group type: COMPARATOR
Intervention: Negative control rinse
Number of subjects: 19
Study: 11740701

Group type: EXPERIMENTAL
Intervention: Clarithromycin (15 mg/kg/day in 2 divided doses for 7 days)
Number of subjects: 87

Group type: COMPARATOR
Intervention: Azithromycin (10 mg/kg/day in 1 dose for 3 days)
Number of subjects: 87
Study: 9420339

Group type: EXPERIMENTAL
Intervention: Pravastatin
Number of subjects: 807

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 807
Study: 7798635

Group type: EXPERIMENTAL
Intervention: UVB-exposed skin sensitization with hapten
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Normal skin sensitization with hapten
Number of subjects: 0
Study: 2192379

Group type: EXPERIMENTAL
Intervention: Freeze-dried Urtica dioica
Number of subjects: 98

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 98
Study: 221691

Group type: EXPERIMENTAL
Intervention: 2-deoxy-D-glucose
Number of subjects: 36

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 36
Study: 31278446

Group type: EXPERIMENTAL
Intervention: Intraarticular tenodesis (IA) using an anchor suture for rotator cuff repair and LHBT tenodesis
Number of subjects: 60

Group type: COMPARATOR
Intervention: Open subpectoral tenodesis (SP) using an interference screw after arthroscopic repair of the rotator cuff
Number of subjects: 60
Study: 27997198

Group type: EXPERIMENTAL
Intervention: LIPDOX
Number of subjects: 25

Group type: COMPARATOR
Intervention: DEBDOX
Number of subjects: 25
Study: 25876892

Group type: EXPERIMENTAL
Intervention: Jaundice-reducing group (biliary drainage)
Number of subjects: 105

Group type: COMPARATOR
Intervention: Non-reducing group (no biliary drainage)
Number of subjects: 105

Group type: EXPERIMENTAL
Intervention: Jaundice-reducing group
Number of subjects: 105

Group type: COMPARATOR
Intervention: Non-reducing group
Number of subjects: 105
Study: 23579517

Group type: EXPERIMENTAL
Intervention: Standard-pressure pneumoperitoneum (12 to 14 mmHg)
Number of subjects: 68

Group type: COMPARATOR
Intervention: Low-pressure pneumoperitoneum (6 to 8 mmHg)
Number of subjects: 68
Study: 21741519

Group type: EXPERIMENTAL
Intervention: LigaSure
Number of subjects: 60

Group type: COMPARATOR
Intervention: Clamp-and-tie
Number of subjects: 60
Study: 19259717

Group type: EXPERIMENTAL
Intervention: ANN-guided CPAP titration
Number of subjects: 115

Group type: COMPARATOR
Intervention: Conventional CPAP titration
Number of subjects: 115

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 115
Study: 16707149

Group type: EXPERIMENTAL
Intervention: Low-sodium, high-vitamin C and -carotene diet
Number of subjects: 550
Study: 15229100

Group type: EXPERIMENTAL
Intervention: Fluticasone (500 mcg twice a day)
Number of subjects: 41

Group type: EXPERIMENTAL
Intervention: Oral prednisone (30 mg/day)
Number of subjects: 41

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 41

Group type: EXPERIMENTAL
Intervention: Fluticasone (500 mcg twice a day for an additional 8 weeks)
Number of subjects: 41
Study: 11395591

Group type: EXPERIMENTAL
Intervention: Diltiazem (25 mg bolus followed by 20 mg/hr continuous infusion for 24 hrs)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Amiodarone (300 mg bolus)
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Amiodarone (300 mg bolus followed by 45 mg/hr for 24 hrs)
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Diltiazem
Number of subjects: 60
Study: 9244941

Group type: EXPERIMENTAL
Intervention: Propofol (0.8‐1 mg/kg for induction; 4‐6 mg/kg/h for maintenance)
Number of subjects: 48

Group type: COMPARATOR
Intervention: Etomidate (0.25 mg/kg for induction) and isoflurane (0.6‐0.8% for maintenance)
Number of subjects: 48

Group type: EXPERIMENTAL
Intervention: Propofol
Number of subjects: 48

Group type: COMPARATOR
Intervention: Etomidate and isoflurane
Number of subjects: 48
Study: 8299077

Group type: EXPERIMENTAL
Intervention: Methotrexate/5-fluorouracil (5-FU) followed by leucovorin rescue (MFL)
Number of subjects: 70

Group type: COMPARATOR
Intervention: 5-fluorouracil/leucovorin (FLV)
Number of subjects: 70

Group type: EXPERIMENTAL
Intervention: Not specified
Number of subjects: 70
Study: 2567893

Group type: EXPERIMENTAL
Intervention: tranexamic acid (TA group)
Number of subjects: 12

Group type: COMPARATOR
Intervention: placebo (control group)
Number of subjects: 12
Study: 30285594

Group type: EXPERIMENTAL
Intervention: Live-animal training
Number of subjects: 38

Group type: COMPARATOR
Intervention: Online video instruction
Number of subjects: 38
Study: 28468030

Group type: EXPERIMENTAL
Intervention: Tai Chi practitioners
Number of subjects: 34

Group type: COMPARATOR
Intervention: Sedentary individuals
Number of subjects: 34
Study: 26293443

Group type: EXPERIMENTAL
Intervention: BUP at a dose of 150mg/day for 3 days, subsequently increased to 300mg/day
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Nicotine gum of 4mg every 1-2 hourly for initial 6 weeks, then every 2-4 hourly for next 6 weeks
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Behavioral Intervention (BI)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Behavioral Intervention (BI) + BUP
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Behavioral Intervention (BI) + Nicotine Replacement Therapy (NRT)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: BUP + NRT + BI
Number of subjects: 0
Study: 23834653

Group type: EXPERIMENTAL
Intervention: Sivelestat (0.2 mg/kg/h continuous intravenous infusion)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Control (0.9% saline)
Number of subjects: 30
Study: 21810633

Group type: EXPERIMENTAL
Intervention: Home-based early intervention with 5 or 6 home visits from a specially trained research nurse
Number of subjects: 667

Group type: EXPERIMENTAL
Intervention: Home-based early intervention
Number of subjects: 667
Study: 19041336

Group type: EXPERIMENTAL
Intervention: Minocycline
Number of subjects: 12

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 12
Study: 16960287

Group type: EXPERIMENTAL
Intervention: Restrictive transfusion strategy (hemoglobin 7.0 g/dL maintained between 7.0 and 9.0 g/dL)
Number of subjects: 67

Group type: COMPARATOR
Intervention: Liberal transfusion strategy (hemoglobin 10.0 g/dL maintained between 10.0 and 12.0 g/dL)
Number of subjects: 67

Group type: EXPERIMENTAL
Intervention: Restrictive transfusion strategy
Number of subjects: 67

Group type: COMPARATOR
Intervention: Liberal transfusion strategy
Number of subjects: 67
Study: 15663681

Group type: COMPARATOR
Intervention: Orchiectomy alone (O)
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Orchiectomy plus flutamide (OF)
Number of subjects: 100
Study: 11583604

Group type: EXPERIMENTAL
Intervention: Not available
Number of subjects: 0
Study: 9240801

Group type: COMPARATOR
Intervention: Routine verbal and written instructions
Number of subjects: 627

Group type: COMPARATOR
Intervention: Reminder phone call
Number of subjects: 627

Group type: COMPARATOR
Intervention: Transportation tokens and toy on return
Number of subjects: 627

Group type: COMPARATOR
Intervention: Withholding of school forms until time of reading
Number of subjects: 627

Group type: COMPARATOR
Intervention: Parents taught to read induration with nurse home visit
Number of subjects: 627
Study: 8106653

Group type: EXPERIMENTAL
Intervention: Paroxetine (10 to 50 mg/day)
Number of subjects: 433
Study: 3539709

Group type: EXPERIMENTAL
Intervention: Intravenous branched chain amino acids in 20% dextrose (group A)
Number of subjects: 59

Group type: COMPARATOR
Intervention: Oral lactulose (group B)
Number of subjects: 59

Group type: EXPERIMENTAL
Intervention: Intravenous branched chain amino acids (preliminary uncontrolled study)
Number of subjects: 59
Study: 29614696

Group type: EXPERIMENTAL
Intervention: Subthalamic deep brain stimulation at various frequencies (40-160 Hz, 40 Hz intervals)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Higher frequencies (>80 Hz)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Lower frequencies (40 Hz)
Number of subjects: 20
Study: 30641005

Group type: EXPERIMENTAL
Intervention: Chang'an Recipe I (CR I)
Number of subjects: 58

Group type: COMPARATOR
Intervention: CR I placebo
Number of subjects: 58
Study: 24439531

Group type: EXPERIMENTAL
Intervention: Exercise class emphasizing health outcomes
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Exercise class emphasizing appearance outcomes
Number of subjects: 0
Study: 22561549

Group type: EXPERIMENTAL
Intervention: Ultrabrief-pulse ECT (0.3 ms)
Number of subjects: 25

Group type: COMPARATOR
Intervention: Brief-pulse ECT (1 ms)
Number of subjects: 25
Study: 22126534

Group type: COMPARATOR
Intervention: Traditional lumbar exercise
Number of subjects: 4325

Group type: COMPARATOR
Intervention: Core stabilization exercise
Number of subjects: 4325

Group type: EXPERIMENTAL
Intervention: Traditional lumbar exercise with psychosocial education
Number of subjects: 4325

Group type: EXPERIMENTAL
Intervention: Core stabilization with psychosocial education
Number of subjects: 4325
Study: 18633000

Group type: EXPERIMENTAL
Intervention: Home Care Activity Desk (HCAD) training
Number of subjects: 81

Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 81
Study: 16100705

Group type: EXPERIMENTAL
Intervention: Physical activity intervention (12 weeks)
Number of subjects: 83
Study: 14587302

Group type: EXPERIMENTAL
Intervention: High dose triple therapy (omeprazole, amoxicillin, clarithromycin) for 1 week
Number of subjects: 225

Group type: EXPERIMENTAL
Intervention: Low dose triple therapy (omeprazole, amoxicillin, clarithromycin) for 1 week
Number of subjects: 225

Group type: COMPARATOR
Intervention: Failed eradication therapy
Number of subjects: 225
Study: 10740541

Group type: EXPERIMENTAL
Intervention: Aprotinin (high-dose regimen)
Number of subjects: 57

Group type: COMPARATOR
Intervention: Saline (control group)
Number of subjects: 57
Study: 9082107

Group type: EXPERIMENTAL
Intervention: Nonsuction drainage
Number of subjects: 80

Group type: COMPARATOR
Intervention: High-vacuum drainage
Number of subjects: 80
Study: 1387351

Group type: EXPERIMENTAL
Intervention: Intravenous sufentanil (150 micrograms)
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Epidural sufentanil (150 micrograms)
Number of subjects: 20
Study: 6572128

Group type: EXPERIMENTAL
Intervention: 0.76% sodium monofluorophosphate dentifrice
Number of subjects: 751

Group type: EXPERIMENTAL
Intervention: 0.05% sodium fluoride mouthrinse
Number of subjects: 751

Group type: EXPERIMENTAL
Intervention: Combined use of dentifrice and mouthrinse
Number of subjects: 751
Study: 31208125

Group type: EXPERIMENTAL
Intervention: Individual six‐month‐long physical exercise program (group I)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Standard physical activity program (group II)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group (group III)
Number of subjects: 0
Study: 27870557

Group type: EXPERIMENTAL
Intervention: Stress task
Number of subjects: 39

Group type: EXPERIMENTAL
Intervention: Smoking images
Number of subjects: 39

Group type: COMPARATOR
Intervention: Neutral images
Number of subjects: 39

Group type: COMPARATOR
Intervention: Motivational control images
Number of subjects: 39

Group type: EXPERIMENTAL
Intervention: Visual cue task completed first
Number of subjects: 39

Group type: EXPERIMENTAL
Intervention: Stress task completed first
Number of subjects: 39
Study: 25034950

Group type: EXPERIMENTAL
Intervention: High saturated fat meal
Number of subjects: 58

Group type: COMPARATOR
Intervention: High oleic sunflower oil meal
Number of subjects: 58

Group type: EXPERIMENTAL
Intervention: Participants with prior MDD and more stressors
Number of subjects: 58
Study: 24378144

Group type: EXPERIMENTAL
Intervention: Motivational interviewing
Number of subjects: 154

Group type: COMPARATOR
Intervention: Usual approach (control group)
Number of subjects: 154
Study: 22840231

Group type: COMPARATOR
Intervention: 30% oxygen
Number of subjects: 35

Group type: EXPERIMENTAL
Intervention: 80% oxygen
Number of subjects: 35
Study: 19651344

Group type: EXPERIMENTAL
Intervention: Damon 3 self-ligating bracket
Number of subjects: 66

Group type: COMPARATOR
Intervention: Tru Straight conventional twin bracket
Number of subjects: 66

Group type: EXPERIMENTAL
Intervention: Analgesics taken
Number of subjects: 66

Group type: COMPARATOR
Intervention: No analgesics taken
Number of subjects: 66
Study: 17804348

Group type: EXPERIMENTAL
Intervention: Peer support intervention for promoting antiretroviral therapy adherence
Number of subjects: 9
Study: 14987268

Group type: EXPERIMENTAL
Intervention: 6 treatments of psoralen‐UVA (PUVA) therapy
Number of subjects: 8

Group type: COMPARATOR
Intervention: 12 treatments of psoralen‐UVA (PUVA) therapy
Number of subjects: 8
Study: 11475855

Group type: EXPERIMENTAL
Intervention: Exercise test (modified Bruce protocol)
Number of subjects: 53
Study: 9551739

Group type: EXPERIMENTAL
Intervention: Fish oil capsules plus canola oil and margarine (omega‐3 group)
Number of subjects: 39

Group type: COMPARATOR
Intervention: Safflower oil capsules plus sunflower oil and margarine (omega‐6 group)
Number of subjects: 39
Study: 7998418

Group type: EXPERIMENTAL
Intervention: TGP-943 vaccine
Number of subjects: 2137
Study: 3045202

Group type: EXPERIMENTAL
Intervention: Calcium supplementation (1 g/day) for 8 weeks
Number of subjects: 23

Group type: EXPERIMENTAL
Intervention: Calcium supplementation (1 g/day) for 8 weeks followed by 1,25-(OH)2 vitamin D3 (0.5 micrograms/day) for 2 weeks
Number of subjects: 23

Group type: EXPERIMENTAL
Intervention: Calcium plus 1,25-(OH)2 vitamin D3
Number of subjects: 23
Study: 30986442

Group type: EXPERIMENTAL
Intervention: Brolucizumab 6 mg
Number of subjects: 1817

Group type: EXPERIMENTAL
Intervention: Brolucizumab 3 mg
Number of subjects: 1817

Group type: COMPARATOR
Intervention: Aflibercept 2 mg
Number of subjects: 1817

Group type: EXPERIMENTAL
Intervention: Brolucizumab
Number of subjects: 1817

Group type: COMPARATOR
Intervention: Brolucizumab and Aflibercept
Number of subjects: 1817
Study: 30672249

Group type: EXPERIMENTAL
Intervention: 2 Hz/100 Hz TEAS combined with wristband pressing
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: 2 Hz TEAS combined with wristband pressing
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: 100 Hz TEAS combined with wristband pressing
Number of subjects: 80

Group type: COMPARATOR
Intervention: Postoperative routine care
Number of subjects: 80
Study: 29138394

Group type: EXPERIMENTAL
Intervention: In silico system with a two-peak fitness landscape
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Genetic crossovers
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Population size
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Number of genes
Number of subjects: 0
Study: 25817323

Group type: EXPERIMENTAL
Intervention: Therapist-supervised therapy provided by a certified hand therapist (CHT)
Number of subjects: 50

Group type: COMPARATOR
Intervention: Home exercise program instructed and monitored by a certified hand therapist (CHT)
Number of subjects: 50
Study: 23442554

Group type: EXPERIMENTAL
Intervention: Conventional arthroscopic partial meniscectomy
Number of subjects: 0

Group type: COMPARATOR
Intervention: Sham surgery procedure
Number of subjects: 0
Study: 21228246

Group type: EXPERIMENTAL
Intervention: Basal-bolus insulin regimen (glargine once daily and glulisine before meals)
Number of subjects: 211

Group type: COMPARATOR
Intervention: Sliding scale regular insulin (SSI) four times daily
Number of subjects: 211

Group type: EXPERIMENTAL
Intervention: Basal-bolus insulin regimen
Number of subjects: 211

Group type: COMPARATOR
Intervention: Sliding scale regular insulin (SSI)
Number of subjects: 211
Study: 18820311

Group type: EXPERIMENTAL
Intervention: Blind intra-articular injections (IAIs) in peripheral joints
Number of subjects: 96
Study: 16801461

Group type: EXPERIMENTAL
Intervention: Cardiac Resynchronization Therapy (CRT)
Number of subjects: 813

Group type: COMPARATOR
Intervention: Pharmacological therapy alone (Control)
Number of subjects: 813

Group type: EXPERIMENTAL
Intervention: Cardiac Resynchronization Therapy (CRT) in patients with new-onset AF
Number of subjects: 813
Study: 12717395

Group type: EXPERIMENTAL
Intervention: HHT with liver involvement
Number of subjects: 95

Group type: COMPARATOR
Intervention: HHT without liver involvement
Number of subjects: 95

Group type: COMPARATOR
Intervention: Cirrhosis
Number of subjects: 95

Group type: COMPARATOR
Intervention: Healthy controls
Number of subjects: 95
Study: 11035135

Group type: EXPERIMENTAL
Intervention: SR 49059 (300 mg once daily)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 20
Study: 9385122

Group type: EXPERIMENTAL
Intervention: Raloxifene 60 mg daily
Number of subjects: 601

Group type: EXPERIMENTAL
Intervention: Raloxifene (all doses)
Number of subjects: 601

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 601
Study: 1539846

Group type: EXPERIMENTAL
Intervention: PCA supplemented with a nighttime infusion of morphine 1.0 mg.h-1
Number of subjects: 156

Group type: COMPARATOR
Intervention: PCA alone
Number of subjects: 156
Study: 4002749

Group type: EXPERIMENTAL
Intervention: Psychotherapy (including autogenous training)
Number of subjects: 16

Group type: COMPARATOR
Intervention: Symptomatic treatment
Number of subjects: 16